Noodles & Company Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:06 pm UTC| Business
BROOMFIELD, Colo., Nov. 03, 2016 -- Noodles Company (NASDAQ:NDLS) today announced financial results for its third quarter ended September27, 2016. Key highlights for the third quarter of 2016 versus the same quarter...
Mad Catz® Reports Fiscal 2017 Second Quarter Financial Results
Nov 03, 2016 20:06 pm UTC| Business
SAN DIEGO, Nov. 03, 2016 -- Mad Catz Interactive, Inc. (“Mad Catz” or the “Company”) (NYSE MKT:MCZ), today announced financial results for the fiscal 2017 second quarter ended September 30, 2016. Key Highlights of...
Mad Catz® Reports Fiscal 2017 Second Quarter Financial Results
Nov 03, 2016 20:06 pm UTC| Business
SAN DIEGO, Nov. 03, 2016 -- Mad Catz Interactive, Inc. (“Mad Catz” or the “Company”) (NYSE MKT:MCZ), today announced financial results for the fiscal 2017 second quarter ended September 30, 2016. Key Highlights of...
ConforMIS Reports Third Quarter 2016 Financial Results
Nov 03, 2016 20:06 pm UTC| Business
BEDFORD, Mass., Nov. 03, 2016 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
ConforMIS Reports Third Quarter 2016 Financial Results
Nov 03, 2016 20:06 pm UTC| Business
BEDFORD, Mass., Nov. 03, 2016 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
TESARO Announces Third-Quarter 2016 Operating Results
Nov 03, 2016 20:06 pm UTC| Business
Niraparib rolling NDA submission to FDA complete, MAA accepted for review by EMAPre-launch planning ongoing to support four potential product launches in 2017 across U.S. and EuropePositive Phase 3 NOVA trial results...
TESARO Announces Third-Quarter 2016 Operating Results
Nov 03, 2016 20:06 pm UTC| Business
Niraparib rolling NDA submission to FDA complete, MAA accepted for review by EMAPre-launch planning ongoing to support four potential product launches in 2017 across U.S. and EuropePositive Phase 3 NOVA trial results...